2 result(s) displayed (1 - 2 of 2):

J&J chief calls job cuts 'difficult' (from Corporate Dealmaker)

Two weeks after Johnson & Johnson (NYSE:JNJ) reported mixed earnings, which tugged stocks downward, the world's biggest healthcare company is looking to cut costs. Those cuts include 7,000 to 8,000 layoffs, mostly overseas.J&J chief executive William Weldon (pictured) said in a statement, "These types of changes are difficult under any...

Posted on November 3, 2009 4:11 PM

Merck spends $130M as it enters risky market (from Corporate Dealmaker)

Chalk up another 2009 pharma deal following Pfizer Inc.'s trend setting mega-acquisition of Wyeth. Whitehouse Station, N.J.-based Merck & Co. is acquiring Insmed Inc.'s portfolio of follow-on biologic (or "biosimilar") drugs and its commercial manufacturing facilities in Boulder, Colo., for $130 million. Merck announced plans to enter the so-called biosimilar...

Posted on February 12, 2009 9:23 AM